echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurology: After cerebral hemorrhage, which epilepsy prevention method is better?

    JAMA Neurology: After cerebral hemorrhage, which epilepsy prevention method is better?

    • Last Update: 2021-09-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

    Acute symptomaticSeizures (early seizures, ≤7 days after stroke ) are a common complication of spontaneous intracerebral hemorrhage (sICH)
    .


    In adult patients, the estimated risk of early seizures is between 10% and 19%


    Epilepsy stroke

    In the case of epileptic seizure prevention after sICH , the recommendations of the guidelines are inconsistent with current clinical practice, perhaps partly because of the lack of high-quality clinical trials
    .

    The recommendations of the prevention guidelines are inconsistent with current clinical practice, perhaps partly because of the lack of high-quality clinical trials
    .


    Although potential safety issues have prompted people to recommend against using antiepileptic drugs as the main preventive measure, the literature shows that approximately 40% of American sICH patients receive preventive intravenous drugs before the development of epilepsy
    .

    Because the risk of seizures is a key factor in determining which patient groups may benefit the most from different prevention strategies, effective tools for predicting the risk of early (such as 2HELPS2Bscore) and late seizures can help doctors make treatment decisions
    .


    However, no clinical trials or prospective studies have evaluated the net benefits of various strategies after sICH


    Therefore, Felipe JS Jone and others at Harvard University Massachusetts General Hospital used simulation model and decision analysis, combined with current knowledge, according to the type of treatment (primary and secondary prevention), the time of the event ( Early and late onset) and duration of treatment (1 week [short-term] and indefinite [long-term] treatment), to evaluate the trade-offs related to the 4 treatment strategies
    .

    These strategies include:
    (1) Conservative short-term secondary prevention after early onset and long-term treatment after late onset;
    (2) Moderate long-term secondary prevention after early onset or long-term secondary treatment after late onset;
    (3) Active the long-term primary prevention
    (4) low-risk patients (2HELPS2B risk score) early short-term secondary prevention in post-attack risk guidance, short-term primary prevention of high-risk patients, and after two late onset of long-term treatment
    .

    The aim is to explore which option is related to the greatest net benefit, measured in expected quality-adjusted life years (QALYs)
    .

    The aim is to explore which option is related to the greatest net benefit, measured in expected quality-adjusted life years (QALYs)
    .



    The decision analysis uses the model to simulate the following 4 common situations
    .



    (2) An 80-year-old woman with early (10%) and late (3.


    6% or 9.
    8


    (3) A 55-year-old man has a high risk of early (19%) and late (34.


    8% or 46.
    2%) seizures and a low short-term (9%) and long-term (30%) ADR risk;

    (4) A 45-year-old woman has a high risk of early (19%) and late (34.


    8% or 46.
    2%) onset and high short-term (18%) and long-term (60%) ADR risk


    Intervention measures: including the following 4 anti-epileptic drug strategies
    .



    Main clinical outcome: Quality-adjusted life years (QALYs)
    .

    They found:

    For Scenario 1, risk guidance strategies (8.


    13 QALYs) are more popular than conservative (8.
    08 QALYs), moderate (8.
    07 QALYs) and active (7.
    88 QALYs) strategies
    .

    For Scenario 2, conservative strategies (2.
    18 QALYs) are more popular than risk guidance (2.
    17 QALYs), moderate (2.
    09 QALYs) and aggressive (1.
    15 QALYs) strategies
    .

    For Scenario 3, active strategies (9.
    21 QALYs) are more popular than risk-guided (8.
    98 QALYs), moderate (8.
    93 QALYs) and conservative (8.
    77 QALYs) strategies
    .

    For Scenario 4, risk guidance strategies (11.
    53 QALYs) are more popular than conservative (11.
    23 QALYs), moderate (10.
    93 QALYs) and aggressive (8.
    08 QALYs) strategies
    .

    Sensitivity analysis shows that in most cases, short-term strategies (conservative and risk guidance) are the first choice, and in most cases, the performance of risk guidance strategies is equal to or better than alternative strategies
    .

    This decision analysis model shows that short-term (7-day) preventive measures are dominant in long-term treatment after sICH
    .
    For all patients after sICH, the 2HELPS2B score should be considered to guide the clinical decision to initiate short-term primary or secondary early-seizure prophylaxis
    .

    Short-term (7 days) preventive measures are dominant in long-term treatment after sICH


    Original source:


    Jones FJS, Sanches PR, Smith JR, et al.
    Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage.
    JAMA Neurol.
    Published online July 26, 2021.
    doi:10.
    1001/jamaneurol.
    2021.
    2249

    Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage.
    JAMA is here to leave a message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.